Related Experiment Video
Updated: Aug 5, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
A Summary on Tuberculosis Vaccine Development-Where to Go?
Fan Jiang1,2, Tiehui Sun3, Peng Cheng1
1Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing 100091, China.
This bibliometric analysis reveals a significant increase in tuberculosis (TB) vaccine research over 20 years. Future TB vaccine development will focus on host-pathogen interactions.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Tuberculosis (TB) remains a significant global infectious disease.
- Vaccination is crucial for TB prevention and control.
- Bibliometric analysis of TB vaccine research progress is limited.
Purpose of the Study:
- To systematically analyze TB vaccine research over the past two decades.
- To identify current research priorities and future directions in TB vaccine development.
Main Methods:
- Bibliometric analysis of publications from the Science Citation Index Expanded (SCI-E) database.
- Utilized VOSviewer, CiteSpace, and Bibliometrix for data visualization and analysis.
- Statistical analysis performed using GraphPad Prism and Microsoft Excel.
Main Results:
- 7960 publications on TB vaccines identified between 2002 and 2022.
- The United States, United Kingdom, and China are leading contributors.
- Future research trends indicate a focus on host-pathogen interaction mechanisms.
Conclusions:
- TB vaccine research has shown substantial growth over the last two decades.
- Developed nations lead TB vaccine research, with developing countries rapidly advancing.
- Future TB vaccine development will likely concentrate on molecular mechanisms of host-pathogen interactions.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Vaccinations

